Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Is large-scale rapid CoV-2 testing a substitute for lockdowns?

Marc Diederichs, René Glawion, Peter G. Kremsner, Timo Mitze, Gernot J. Müller, Dominik Papies, Felix Schulz, Klaus Wälde
doi: https://doi.org/10.1101/2021.04.26.21256094
Marc Diederichs
1Johannes Gutenberg University Mainz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
René Glawion
2University of Hamburg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter G. Kremsner
3University of Tübingen
4Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timo Mitze
5University of Southern Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gernot J. Müller
3University of Tübingen
6CESifo
7CEPR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dominik Papies
3University of Tübingen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Felix Schulz
1Johannes Gutenberg University Mainz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Klaus Wälde
1Johannes Gutenberg University Mainz
6CESifo
8IZA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: waelde@uni-mainz.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

BACKGROUND Various forms of contact restrictions have been adopted in response to the Covid-19 pandemic. Around February 2021, rapid testing appeared as a new policy instrument. Some claim it may serve as a substitute for contact restrictions.

OBJECTIVES/METHODS We evaluate the effects of a unique policy experiment: In March and April 2021, the city of Tübingen set up a testing scheme while relaxing contact restrictions. We compare case rates in Tübingen county to an appropriately identified control unit.

CONCLUSIONS The experiment led to an increase in the reported case rate. This increase is robust across alternative statistical specifications. An epidemiological model that corrects for ‘more cases due to more testing’ and ‘reduced testing and reporting during the Easter holiday’ also confirms the finding.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

no external funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

not required

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

all data is public

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 06, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Is large-scale rapid CoV-2 testing a substitute for lockdowns?
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Is large-scale rapid CoV-2 testing a substitute for lockdowns?
Marc Diederichs, René Glawion, Peter G. Kremsner, Timo Mitze, Gernot J. Müller, Dominik Papies, Felix Schulz, Klaus Wälde
medRxiv 2021.04.26.21256094; doi: https://doi.org/10.1101/2021.04.26.21256094
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Is large-scale rapid CoV-2 testing a substitute for lockdowns?
Marc Diederichs, René Glawion, Peter G. Kremsner, Timo Mitze, Gernot J. Müller, Dominik Papies, Felix Schulz, Klaus Wälde
medRxiv 2021.04.26.21256094; doi: https://doi.org/10.1101/2021.04.26.21256094

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (174)
  • Allergy and Immunology (420)
  • Anesthesia (97)
  • Cardiovascular Medicine (896)
  • Dentistry and Oral Medicine (169)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (405)
  • Epidemiology (8768)
  • Forensic Medicine (4)
  • Gastroenterology (404)
  • Genetic and Genomic Medicine (1857)
  • Geriatric Medicine (177)
  • Health Economics (387)
  • Health Informatics (1287)
  • Health Policy (643)
  • Health Systems and Quality Improvement (491)
  • Hematology (206)
  • HIV/AIDS (392)
  • Infectious Diseases (except HIV/AIDS) (10545)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1749)
  • Nursing (102)
  • Nutrition (265)
  • Obstetrics and Gynecology (342)
  • Occupational and Environmental Health (461)
  • Oncology (962)
  • Ophthalmology (281)
  • Orthopedics (107)
  • Otolaryngology (176)
  • Pain Medicine (117)
  • Palliative Medicine (41)
  • Pathology (263)
  • Pediatrics (556)
  • Pharmacology and Therapeutics (264)
  • Primary Care Research (218)
  • Psychiatry and Clinical Psychology (1841)
  • Public and Global Health (3976)
  • Radiology and Imaging (651)
  • Rehabilitation Medicine and Physical Therapy (341)
  • Respiratory Medicine (534)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (196)
  • Toxicology (37)
  • Transplantation (106)
  • Urology (79)